0.240
0.24 (-1.02%)
As of Dec 22, 2021
Ayala Pharmaceuticals, Inc. [ADXS]
Source:
Company Overview
Ayala Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm Technology antigen delivery products based on a platform technology that utilizes live attenuated Listeria monocytogenes, or Lm, bioengineered to secrete antigen/adjuvant fusion proteins.
Country | United States |
Headquarters | monmouth junction, new jersey |
Phone Number | 732 545 1590 |
Industry | manufacturing |
CEO | Kenneth Berlin |
Website | ayalapharma.com |